Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
Authors
Keywords
Hyperkalaemia, Serum potassium; chronic kidney disease, Mortality, Major adverse cardiac event, RAASi discontinuation
Journal
BMC Nephrology
Volume 19, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-22
DOI
10.1186/s12882-018-1007-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study
- (2017) W. Ouwerkerk et al. EUROPEAN HEART JOURNAL
- Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry
- (2017) Michel Komajda et al. EUROPEAN JOURNAL OF HEART FAILURE
- Impact of admission serum potassium on mortality in patients with chronic kidney disease and cardiovascular disease
- (2017) W Cheungpasitporn et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials
- (2016) Xinfang Xie et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
- (2016) Gemma Currie et al. BMC Nephrology
- Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arena
- (2016) Murray Epstein Kidney International Supplements
- Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease
- (2015) Georges N. Nakhoul et al. AMERICAN JOURNAL OF NEPHROLOGY
- Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function
- (2015) J. Luo et al. Clinical Journal of the American Society of Nephrology
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)
- (2015) Emily Herrett et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease
- (2012) Nishank Jain et al. AMERICAN JOURNAL OF CARDIOLOGY
- Notice
- (2012) Kidney International Supplements
- Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial
- (2011) Marc Evans et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Association of Hypo- and Hyperkalemia with Disease Progression and Mortality in Males with Chronic Kidney Disease: The Role of Race
- (2011) John Hayes et al. NEPHRON CLINICAL PRACTICE
- Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study
- (2010) S. Korgaonkar et al. Clinical Journal of the American Society of Nephrology
- The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
- (2009) Lisa M. Einhorn et al. ARCHIVES OF INTERNAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now